| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1023932721 |
| P356 | DOI | 10.1186/S12891-016-1275-5 |
| P8608 | Fatcat ID | release_nbkgre7fnfhj7on2nfafhrpily |
| P932 | PMC publication ID | 5062857 |
| P698 | PubMed publication ID | 27737664 |
| P2093 | author name string | Joachim Sieper | |
| Anish Mehta | |||
| Paul M Peloso | |||
| Zoran Popmihajlov | |||
| Paul Stryszak | |||
| Kara Bickham | |||
| Nancy Frontera | |||
| Eva Balazcs | |||
| P2860 | cites work | Comparative efficacy of non-steroidal anti-inflammatory drugs in ankylosing spondylitis: a Bayesian network meta-analysis of clinical trials | Q38561891 |
| Mortality in ankylosing spondylitis: results from a nationwide population-based study | Q41016710 | ||
| Cardiovascular safety and gastrointestinal tolerability of etoricoxib vs diclofenac in a randomized controlled clinical trial (The MEDAL study). | Q41998132 | ||
| Fatigue in ankylosing spondylitis: treatment should focus on pain management | Q42663885 | ||
| Evaluation of the efficacy of etoricoxib in ankylosing spondylitis: results of a fifty-two-week, randomized, controlled study | Q46428507 | ||
| Nonsteroidal antiinflammatory drugs reduce radiographic progression in patients with ankylosing spondylitis: a randomized clinical trial | Q46525954 | ||
| Effect of non-steroidal anti-inflammatory drugs on radiographic spinal progression in patients with axial spondyloarthritis: results from the German Spondyloarthritis Inception Cohort. | Q47968602 | ||
| Effect of continuous versus on-demand treatment of ankylosing spondylitis with diclofenac over 2 years on radiographic progression of the spine: results from a randomised multicentre trial (ENRADAS). | Q52863510 | ||
| Ankylosing spondylitis | Q54165668 | ||
| Etoricoxib | Q80471891 | ||
| Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials | Q24546221 | ||
| 2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis | Q24603648 | ||
| Assessment of upper gastrointestinal safety of etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison | Q28218927 | ||
| Survey of chronic pain in Europe: Prevalence, impact on daily life, and treatment | Q30458126 | ||
| American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network 2015 Recommendations for the Treatment of Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis | Q30829836 | ||
| Longitudinal numbers-needed-to-treat (NNT) for achieving various levels of analgesic response and improvement with etoricoxib, naproxen, and placebo in ankylosing spondylitis | Q33964496 | ||
| Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria | Q34055060 | ||
| Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison | Q34582722 | ||
| Etoricoxib: a review of its use in the symptomatic treatment of osteoarthritis, rheumatoid arthritis, ankylosing spondylitis and acute gouty arthritis | Q34610283 | ||
| Efficacy of cyclo-oxygenase-2 inhibition by etoricoxib and naproxen on the axial manifestations of ankylosing spondylitis in the presence of peripheral arthritis | Q35554988 | ||
| ASAS/EULAR recommendations for the management of ankylosing spondylitis | Q35637012 | ||
| First update of the current evidence for the management of ankylosing spondylitis with non-pharmacological treatment and non-biologic drugs: a systematic literature review for the ASAS/EULAR management recommendations in ankylosing spondylitis | Q38003531 | ||
| P433 | issue | 1 | |
| P921 | main subject | naproxen | Q1215575 |
| P304 | page(s) | 426 | |
| P577 | publication date | 2016-10-13 | |
| P1433 | published in | BMC Musculoskeletal Disorders | Q15751716 |
| P1476 | title | A randomized, clinical trial to assess the relative efficacy and tolerability of two doses of etoricoxib versus naproxen in patients with ankylosing spondylitis | |
| P478 | volume | 17 |
| Q64235822 | Efficacy of etoricoxib for ankylosing spondylitis: A protocol for systematic review of randomized controlled trial |
| Q91639335 | Indirect comparison of NSAIDs for ankylosing spondylitis: Network meta-analysis of randomized, double-blinded, controlled trials |
| Q94525699 | Therapeutic Potential of Ixekizumab in the Treatment of Ankylosing Spondylitis: A Review on the Emerging Clinical Data |
| Q90155651 | [Current treatment of axial spondylarthritis : Clinical efficacy] |
Search more.